Mutations in human neuroserpin gene cause an autosomal dementia, familial encephalopathy with neuroserpin inclusion bodies (FENIB). We generated and analyzed transgenic mice expressing high levels of either FENIB-type (G392E) or wildtype human neuroserpin in neurons of the central nervous system. G392E neuroserpin accumulated age-dependently in neurons of the neocortex, thalamus, amygdala, pons, and spinal cord of homozygous transgenic mice. Such accumulations were not observed in hemizygous transgenic mice nor in transgenic mice for wild-type neuroserpin. In differential centrifugation of brain homogenates, G392E neuroserpin recovered in the nucleus-rich fraction dramatically increased along with aging, suggesting that the aggregations gradually increase their densities presumably by their conversion into heavier and more compact configurations. In immunoelectron microscopical analyses, immunopositivities for G392E neuroserpin were found not only in endoplasmic reticulum but also in lysosomes. G392E neuroserpin transgenic mice were much more susceptible to seizures induced by kainate administration than nontransgenic mice. Overall, G392E neuroserpin accumulated in the central nervous system neurons of transgenic mice in mutation-, aging-, and gene dosage-dependent manners. The established transgenic mice will be valuable to elucidate not only mechanisms for the formation of G392E neuroserpin aggregations but also pathways for the degradation and/or clearance of the already formed aggregations in neurons.
Neuroserpin (neuron-specific serine protease inhibitor) was initially identified as an axonally secreted protein from neuronal cultures of chicken dorsal root ganglia (1) and belongs to a serine protease inhibitor (serpin) 2 gene family. Neuroserpin is predominantly expressed in neurons of the developing and adult nervous system (2, 3) . The expression pattern in brain and in vitro complex formation studies demonstrated that tissue plasminogen activator is the most probable target protease for neuroserpin (2, 4) . The regulation of neurite outgrowth by neuroserpin has been reported in nerve growth factortreated PC12 cells (5) . The administration of neuroserpin decreased stroke volume and subsequent apoptosis associated with focal ischemia/reperfusion injury (6) and delayed the progression of kainate-induced seizures (7) . These physiological actions of neuroserpin are thought to depend on the modulation of extracellular matrix degradation by proteolytic enzymes such as tissue plasminogen activator. Neuroserpin-deficient mice exhibited selective reduction of locomotor activity in novel environments and a neophobic response to novel objects (8) .
In 1999, a new form of autosomal dementia, familial encephalopathy with neuroserpin inclusion bodies (FENIB), was reported. FENIB is characterized by accumulation of mutant neuroserpin as periodic acid Shiff (PAS)-positive diastase-resistant inclusions within neurons (9 -12) . Until now, four different mutations have been identified in human neuroserpin gene: S49P, S52R, H338R, and G392E. In the post-mortem examination of FENIB patient brains, the most disruptive mutation (G392E) formed much larger and more inclusion bodies compared with the S49P and S52R mutations. Because the earlier onset of the disease and the severity of clinical syndromes were strongly correlated with the magnitude of intracellular accumulation of mutant neuroserpin (11) , neuroserpin accumulation in the central nervous system (CNS) appears to play a central role in the development of FENIB.
Among the known neuroserpin mutants, the biochemical nature of mutant protein has been well characterized in S49P and S52R neuroserpin. The S49P neuroserpin was a poor protease inhibitor and readily formed polymers in vitro (13, 14) . The S52R neuroserpin was trapped as an inactive intermediate that rapidly formed polymers in vitro (15) . Crystal structures of neuroserpin indicated sequential insertion of the reactive center loop of one molecule into ␤-sheet A of another (16) . Cell transfection studies in COS-7 cells have shown that mutant neuroserpin (S49P and S52R) is retained within the endoplas-mic reticulum (ER) as polymers (17) . However, such biochemical studies have not been reported on most severely disruptive mutant neuroserpin (G392E).
The transgenic mice overexpressing wild-type (WT) neuroserpin in CNS showed a marked resistance to CNS injury induced by focal cerebral ischemia (18) , suggesting a neuroprotective role for neuroserpin. Transgenic mice overexpressing mutant neuroserpin (S49P or S52R) in neurons of the CNS have been recently generated and characterized (19) . These mice exhibited morphological, biochemical, and clinical features resembling those found in human FENIB. However, no transgenic mice have been reported that express G392E neuroserpin. In the present study, we generated transgenic mice overexpressing human G392E neuroserpin in neurons of the CNS. The G392E neuroserpin accumulated in CNS neurons of transgenic mice in mutation-, aging-, and gene dosage-dependent manners. The G392E neuroserpin transgenic mice were much more susceptible to seizures induced by kainate administration than nontransgenic (nonTg) mice. The pathological and physiological features of G392E neuroserpin transgenic mice reproduced those of human FENIB. Thus, this transgenic mouse strain will be useful in elucidating the molecular mechanisms of G392E neuroserpin accumulation in neurons and progression of the disease.
EXPERIMENTAL PROCEDURES
Transgene Construction-By using mouse Thy-1.2 genomic DNA fragment (nucleotides 3233-3542; GenBank TM accession number M12379) as a probe, 4.50-kbp EcoRI-XhoI genomic DNA fragment containing mouse Thy-1.2 promoter (20) was cloned from a mouse embryonic stem cell genomic DNA library. WT human neuroserpin cDNA was generated by reverse transcription-PCR on human fetal brain total RNA (Stratagene). Primers used in the PCR were 5Ј-TTC TCG AGG  AAA CTG TTA CAA TAT GGC TTC CTT GG-3Ј and 5Ј-TTG  GAT CCC AGG ACC ATT AGC TTA ATA CTG ATA ACA  TTC C-3Ј; these sequences correspond to the nucleotides  68 -95 and 1502-1471 of human neuroserpin cDNA (GenBank TM accession number Z81326) and contain XhoI and BamHI sites (underlined sequences), respectively. The amplified product was subcloned at the HincII site in pUC118 vector (Takara), and the plasmid was designated as pUC118/HuNS. pUC118/HuNS was digested with SalI (1195) and NsiI (1268), and then the SalI-NsiI 73-bp fragment was replaced with double stranded-oligonucleotides containing G to A mutation at 1256, leading to a replacement of the 392 glycine with glutamic acid. The WT and G392E neuroserpin cDNAs were fully sequenced for their accuracies and ligated between the Thy-1.2 promoter and SV40 polyadenylation signal sequence using XhoI and BamHI sites. The resultant hybrid gene (7.5 kbp) was separated from the pBlueScript SK(Ϫ) (Stratagene) by EcoRI.
Generation of Transgenic Mice-DNA solution (3 ng/l) was microinjected into the pronuclei of fertilized eggs from BDF1 females as described (21) . Identification of transgenic mice was performed by PCR on tail genomic DNA; the sequences of the primers for transgene amplification were 5Ј-CCA GGT TCA CAG TGG AAC AG-3Ј and 5Ј-ATA CAG CAC AGC CAT CCT AC-3Ј. PCR was performed in thermal cycler (Bio-Rad) for 35 cycles with the following parameters: denaturation at 95°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 90 s. Transgenic mice were backcrossed to CD-1 mice more than five times and analyzed. All of the procedures were approved by the Institutional Animal Care and Use Committee guidelines at the University of Toyama.
Northern and Southern Blot Analyses-Northern blot analyses were carried out as described (22) by using 32 P-labeled cDNAs; those were human neuroserpin cDNA (nucleotides 274 -1197; GenBank TM accession number Z81326), mouse neuroserpin cDNA (nucleotides 84 -788; GenBank TM accession number AJ001700), or mouse glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA (nucleotides 151-987; GenBank TM accession number M32599). Washed membranes were exposed to autoradiographic films (BioMax; Kodak). Southern blot was performed on PvuII-digested mouse genomic DNAs using human neuroserpin cDNA (nucleotides 68 -903; GenBank TM accession number Z81326) as a probe. Western Blot Analyses-Each portion of CNS was homogenized using a glass Teflon homogenizer in 9 volumes of homogenizing buffer (0.32 M sucrose, 10 mM Tris-HCl, pH 7.5, 2 mg/ml each of leupeptin and pepstatin A, and 1 mM phenylmethylsulfonyl fluoride). Protein concentrations were determined using protein assay kit (Bio-Rad). Homogenates denatured in the presence of 2% each of SDS and 2-mercaptoethanol for 10 min at 95°C were subjected to SDS-PAGE on an 8% gel. Proteins blotted onto a nitrocellulose membrane (Amersham Biosciences) were incubated with Tris-buffered saline (TBS) containing 0.1% Tween 20 (TBST) and 5% skim milk at room temperature for 1 h and then with goat anti-human neuroserpin antibody (at 1:250 dilution; Santa Cruz Biotechnology; sc-20831), mouse anti-human calnexin antibody (at 1:500 dilution; BD Biosciences; C45520), rabbit anti-horse cytochrome c antibody (at 1:200 dilution; Santa Cruz Biotechnology; sc-7159), or goat anti-mouse GAPDH antibody (at 1:200 dilution; Santa Cruz Biotechnology; sc-20357) for 1 h. After washing excess antibodies off with TBST, the immunoreactive proteins were visualized using an ECL system coupled with horseradish peroxidase-conjugated secondary antibodies (at 1:5000 dilution; Amersham Biosciences).
Densitometric Analyses-Computer-aided densitometric analyses using image analyzing software "ImageJ" were performed to establish a reliable standardization by an internal control. The GAPDH mRNA/protein, which is constitutively expressed in almost all of the tissues, was selected for an internal control. Relative mRNA or protein levels for human neuroserpin were expressed as ratios between the densities of bands corresponding to human neuroserpin and those to mouse GAPDH. Statistical significances were analyzed by a Student's t test. Significance was assumed at a p value of 0.05.
Immunohistochemistry-The mice were anesthetized with pentobarbital and transcardinally perfused with phosphatebuffered saline. The excised brain and spinal cord were fixed in Gendre's fixative (a mixture of ethanol, formaldehyde, and acetic acid) at 4°C overnight and embedded in paraffin. Following sectioning, the slides were deparaffinized and immersed in 0.3% H 2 O 2 for 10 min. They were then preincubated with blocking reagent (DAKO) for 10 min, followed by overnight incubation in the presence of goat anti-human neuroserpin antibody (at 1:500 dilution) at 4°C. After washing, sections were incubated with Histofine Simple Stain MAX-PO(G) (NICHIREI) for 30 min. Following several washes with TBS, the sections were reacted in a diaminobenzidine solution and then counterstained with Mayer's hematoxylin for 30 s.
Subcellular Fractionation-Subcellular fractions were prepared from whole brain homogenates using differential centrifugation (23) . The homogenate was centrifuged at 1,000 ϫ g for 11 min, and the supernatant (S1) was preserved in an ice bath. The pellet was resuspended with the homogenizing buffer and centrifuged at 1,000 ϫ g for 11 min. The resulting pellet was resuspended in homogenizing buffer and harvested as a nuclear fraction (P1). The supernatant from the second centrifugation was combined with the S1 fraction and centrifuged at 17,000 ϫ g for 60 min. The resulting pellet was resuspended in homogenizing buffer and harvested as a mitochondrial fraction (P2). The supernatant (S2) was centrifuged at 100,000 ϫ g for 60 min, and the resulting supernatant was collected as a cytosolic fraction (S3). The final pellet was resuspended in homogenizing buffer and harvested as a microsomal fraction (P3).
Electron and Immunoelectron Microscopy-The mice were anesthetized with pentobarbital and transcardinally perfused with 0.9% NaCl followed by 1/2 Karnovsky's fixation (2% paraformaldehyde and 2.5% glutaldehyde solution) in 0.1 M phosphate buffer (pH 7.4). The brains were embedded in 7% agar solution, and coronal slices with 100 m-thickness were prepared by a micro-slicer (DTK-1500). The slices were fixed in 1% OsO 4 in 0.2 M phosphate buffer, rinsed in water, and blockstained with 3% uranyl solution. They were dehydrated and embedded in Quetol 812. Ultrathin sections doubly stained with uranyl acetate and lead citrate were examined under JEM-100S electron microscope at an acceleration voltage of 80 kV. For immunoelectron microscopy, sample preparations were performed at 4°C after perfusion with 4% paraformaldehyde containing 0.05% glutaldehyde (pH7.4). They were subjected to cryoprotection by immersion in phosphate-buffered saline containing 15% sucrose. Coronal slices of cerebral cortex with a thickness of 2-3 mm were prepared and treated with the antihuman neuroserpin antibody (at 1:200 dilution). The brain slices were incubated with a peroxidase-conjugated secondary antibody and then incubated with a benzidine chromogen. Ultrathin sections prepared from tissue sections embedded in Epon812 were examined.
Kainate Administration-Kainate (Sigma) was dissolved in 0.9% saline at a concentration of 2.5 mg/ml. The intraperitoneal injection of kainate at a dose of 30 mg/kg body weight was performed on mice at 3 months of age. They were monitored for behavioral seizures by video recording for 3 h. The maximal seizure stage as well as the latency to the first maximal seizure were determined according to the criteria described previously (24) 
RESULTS

Generation of Transgenic Mice Overexpressing Human WT or G392E Neuroserpin in CNS Neurons
-To generate the transgenic mice that express human WT-or G392E neuroserpin, the respective cDNAs were ligated to the mouse Thy-1.2 promoter (Fig. 1A) , which ensures high expression of the transgene in most of the neurons in the CNS (20) . By microinjection into fertilized eggs, we established three independent lines of transgenic mice for G392E neuroserpin (G392E-Tg mice) and three lines of transgenic mice for WT neuroserpin (WT-Tg mice).
In Northern blot analysis using human neuroserpin cDNA as a probe, three lines (lines 183, 819, and 824) of WT neuroserpin transgenic mice but not nonTg mice expressed human neuroserpin mRNA in the brain (Fig. 1B, top panel) . Among the G392E neuroserpin transgenic mice having hemizygous transgenes (G392E hemi -Tg mice), line 333 expressed much higher levels of G392E neuroserpin mRNA than the other lines, 42 and 115. Mice having the homozygous G392E neuroserpin transgenes (G392E homo -Tg mice), which were generated by intercrossing male and female of G392E
hemi -Tg mice of line 333, C, Western blot analysis using anti-human neuroserpin antibody of whole brain homogenate (100 g) of NonTg mice, WT-Tg mice of lines 183, 819, and 824, G392E-Tg mice of lines 42, 115, and 333 at 2 and 6 months of age. X-ray films were exposed to the ECL-reacted membrane for 5 or 40 min.
showed much higher expression of human neuroserpin mRNA than G392E hemi -Tg mice at 2 and 6 months of ages. In Northern blot analysis using mouse neuroserpin cDNA probe, similar but not identical levels of mouse neuroserpin mRNA expression (Fig. 1B, middle panel) were detected in the respective mice. The mouse GAPDH mRNA levels, used as an internal control, did not vary among the mice (Fig. 1B, bottom panel) .
Next we conducted Western blot analysis using anti-human neuroserpin antibody on whole brain homogenates (Fig. 1C) . The three lines (lines 183, 819, and 824) of WT-Tg mice but not nonTg mice contained human neuroserpin protein in the brain at 2 months of age. As expected from Northern blotting (Fig.  1B) , the brain of transgenic line 333 contained the highest level of human neuroserpin polypeptide among the G392E hemi -Tg mice. In the line 333, the amounts of neuroserpin protein in the brain were much increased in the G392E homo -Tg mice when compared with the G392E hemi -Tg mice. The amounts of neuroserpin protein in the G392E homo -Tg mice of line 333 appeared increased at 6 months of age when compared with those at 2 months of age.
Immunohistochemistry of Human Neuroserpin in Transgenic Mouse Brain-By using anti-human neuroserpin antibody, we performed immunohistochemistry in various brain regions of nonTg and G392E
homo -Tg mice of line 333 at 6 months of age. In the G392E homo -Tg mice, human neuroserpin immunoreactivities were observed in widespread neurons in the CNS, with higher levels in the cerebral cortex layer V (Fig. 2D, arrows) , thalamus, and amygdala (Fig. 2E, arrows) , and pons (Fig. 2F,  arrows) . Neurons in the hippocampus, striatum, internal capsule, and cerebellum had a lower prevalence of neuroserpin immunoreactivities (Fig. 2, D-F) . As expected from the results of Western blotting (Fig. 1C) , there were no significant immunoreactivities for human neuroserpin in the nonTg mouse brain (Fig. 2, A-C) , confirming that the antibody reacts to human neuroserpin but not to mouse neuroserpin.
We next examined intracellular localization of expressed neuroserpin at higher magnifications in various brain regions of nonTg, WT-Tg, G392E
hemi -Tg, and G392E homo -Tg mice at 2 and 12 months of age. WT neuroserpin was weakly and diffusely stained in neuronal cell bodies of the cerebral cortex and pons of WT-Tg mice (Fig. 3, A-D) . In contrast, coarse and granular staining patterns for neuroserpin were observed within neuronal cell bodies of the cerebral cortex, pons, and spinal cord in G392E hemi -Tg mice (Fig. 3, E-H) . The immunopositive granules in the cerebral cortex of 12-month-old G392E homo -Tg mice (Fig. 3J, arrows) were much larger in size and greater in number when compared with those in 2-monthold G392E homo -Tg mice (Fig. 3I) . It should be noted that in the neurons of the pons and spinal cord, almost all the area of the perikaryon was occupied by deposits immunopositive for neuroserpin (Fig. 3, K and L, arrows) . In nonTg mice, there were no immunoreactivities for human neuroserpin (Fig. 3, M and N) . In the PAS staining of cerebral cortex and pons of 12-monthold G392E
homo -Tg mice, the neuroserpin deposits appeared PAS-positive (Fig. 3, O and P, arrows) .
Detection of Proteins, Genes, and mRNAs for Human Neuroserpin-We evaluated the levels of accumulated neuroserpin and GAPDH (internal control) in CNS by Western blot analyses. There were no significant changes in the protein levels of human neuroserpin in the brains of WT-Tg and G392E
hemi -Tg mice at 6 and 12 months of age compared with those at 2 months of age (Fig. 4A, top and middle panels) . In contrast, G392E homo -Tg mice accumulated human G392E neuroserpin in an age-dependent manner (Fig. 4A, bottom panel) . The densitometric ratios of human neuroserpin protein to mouse GAPDH protein indicated that there are significant increases of neuroserpin protein levels at 6 and 12 months of age when compared with those of the same genotype at 2 months of age (Fig. 4B) . We then evaluated the accumulation of neuroserpin in various portions of CNS from 2 to 12 months of age. In the G392E homo -Tg mice, the G392E neuroserpin protein but not GAPDH protein age-dependently accumulated in the cerebral cortex, pons, and spinal cord but not in the cerebellum (Fig. 4C) . The densitometric ratios of human neuroserpin protein to mouse GAPDH protein indicated that there are significant increases of neuroserpin protein levels at 6 and/or 12 months of age when compared with those of the same portions at 2 months of age (Fig. 4D) . The significant increases were found in the cerebral cortex, pons, and spinal cord but not in the cerebellum. In Southern blot analysis using human neuroserpin cDNA probe, the G392E homo -Tg mice possessed human neuroserpin transgene in a doubled dosage compared with the G392E hemi -Tg mice (Fig. 4E) . By using human neuroserpin cDNA probe, Northern blot analysis was performed on brain RNAs of WT-Tg, G392E hemi -Tg, and G392E homo -Tg mice (Fig.  4F, upper panel) . In the respective transgenic mice, the levels of human neuroserpin mRNA remained unchanged at 11 or 12 months when compared with those at 2 months. The levels of mouse GAPDH mRNA were at similar levels in all the transgenic mice tested (Fig. 4F, lower panel) . The densitometric ratios of human neuroserpin mRNA to mouse GAPDH mRNA indicated that there are significant increases of human neuroserpin mRNA levels in the G392E homo -Tg mice when compared with those in the age-matched G392E hemi -Tg mice (Fig. 4G) .
Subcellular Fractionation of Human Neuroserpin in Trans-
genic Brains-Next we fractionated whole brain homogenates of various transgenic mice by differential centrifugation (see "Experimental Procedures") and examined neuroserpin levels in each fraction by Western blot analyses (Fig. 5A) . WT human neuroserpin in the WT-Tg mice was predominantly recovered in the microsomal fraction (100,000 ϫ g pellet; P3) and to a lesser amount in the mitochondrial fraction (17,000 ϫ g pellet; P2) fraction. G392E neuroserpin in G392E hemi -Tg mice was largely recovered in the P2 and P3 fractions. In the G392E homo -Tg mice at 2 months of age, G392E neuroserpin was mainly recovered in the P2 and P3 fractions and to a lesser amount in the nuclear fraction (1,000 ϫ g pellet; P1). In the G392E homo -Tg mice at 6 and 12 months of age, the amounts of G392E neuroserpin recovered in the P1 fraction dramatically increased along with aging.
We next determined subcellular localization of neuroserpin, cytochrome c, and calnexin in various types of mice at 12-14 months of age. In the nonTg, WT-Tg, G392E hemi -Tg, and G392E homo -Tg mice, the endogenous cytochrome c was recovered in the P1 and P2 fractions but not in the P3 and S3 fractions (Fig. 5, B-E) . In the nonTg, WT-Tg, and G392E
hemi -Tg mice, the ER marker calnexin was predominantly recovered in the P3 fraction (Fig. 5, B-D) . In the G392E homo -Tg mice, however, calnexin was recovered not only in the P3 fraction but also in the P1 fraction (Fig. 5E) .
Ultrastructural Analyses of Mouse Neurons-Transmission electron microscopy revealed that neocortical neurons of 10-month-old G392E homo -Tg mice have abnormally ballooned structures (Fig. 6B, open arrowheads) . Such abnormal structures were never found in nonTg mice (Fig. 6A) . At higher magnifications, the ballooned structures appeared to be filled with homogenous substances (Fig. 6C, open arrowheads) and encapsulated G392E hemi -Tg mice, and G392E homo -Tg mice at 2, 6, and 12 months of age. B, the densitometric ratios of human neuroserpin protein to mouse GAPDH protein (internal control) were determined at 2, 6, and 12 months of age (n ϭ 3 mice for each point). *, p Ͻ 0.05; **, p Ͻ 0.01 compared with the values for mice of the same genotype at 2 months of age. C, protein homogenates from various regions in CNS were prepared from G392E homo -Tg mice at 2, 4, 6, and 12 months of age. Protein levels for human G392E neuroserpin and mouse GAPDH were determined by Western blot analyses. D, the densitometric ratios of human neuroserpin protein to mouse GAPDH protein (internal control) were determined at 2, 4, 6, and 12 months of age (n ϭ 3 mice for each point). *, p Ͻ 0.05; ***, p Ͻ 0.001 compared with the values for the same portion at 2 months of age. E, a representative result of Southern blot analysis for an estimation of transgene copy numbers in mice. nonTg, nonTg mice; hemi, G392E hemi -Tg mice; homo, G392E homo -Tg mice. F, Northern blot analyses were performed on various genotypes of mice at 2, 11, and 12 months of age using cDNA probes for human neuroserpin and mouse GAPDH. G, the densitometric ratios of human neuroserpin mRNA to mouse GAPDH mRNA (internal control) were determined at 2 and 11 or 12 months of age (n ϭ 3 mice for each point). *, p Ͻ 0.05; ***, p Ͻ 0.001 compared with the values for age-matched G392E hemi -Tg mice. Cx, cerebral cortex; Cb, cerebellum; Po, pons; Sp, spinal cord; Hu NS, human neuroserpin; Mo GAPDH, mouse glyceraldehyde 3-phosphate dehydrogenase. The values are the means Ϯ S.E. The statistical analyses were performed by Student's t test.
with polysome-attached ER membranes (Fig. 6C, arrows) . The ballooned structures were clearly distinguishable from normal ER membranes (Fig. 6, A-C, filled arrowheads) as well as other organelles such as electron-dense lysosomes (Fig. 6C , indicated by L) and mitochondria with a heterogeneous appearance by its laminar structures (Fig. 6, A-C, indicated by M) .
Immunoelectron Microscopy-We performed ultrathin section immunoelectron microscopy with the aid of anti-human neuroserpin antibody (Fig. 6, D-F) . The immunoelectron microscopy revealed that many of the ballooned structures that are irregularly round in shape were immunopositive for human neuroserpin (Fig. 6D, indicated by IP) . In contrast, the ballooned structures that are smoothly round in shape were immunonegative (Fig. 6D, indicated by IN) . Lysosomes with vacuoles were basically positive for human neuroserpin (Fig.  6D, indicated by L) . At higher magnifications, the immunopositive irregular structures appeared to be encapsulated with the ER membranes (Fig. 6, E and F, arrows) .
Increased Susceptibility to Kainate-induced Seizures in G392E Neuroserpin Transgenic Mice-Because FENIB patients with G392E neuroserpin gene exhibited progressive myoclonic epilepsy and status epilepticus (11), WT-Tg, G392E
hemi -Tg, and G392E
homo -Tg mice at 3 months of age were examined for susceptibility to kainate-induced seizures and compared with that of age-matched nonTg mice. The latency to the first maximal seizure and maximal seizure stage were determined according to the criteria as described previously (24) . As shown in Fig. 7 , the latencies to the first maximal seizure were 120 Ϯ 20.3 min for nonTg mice, 123.9 Ϯ 20.1 min for WT-Tg mice, 59.4 Ϯ 16.8* min for G392E hemi -Tg mice, and 49.8 Ϯ 3.9** min for G392E
homo -Tg mice (n ϭ 9 for each group, *, p Ͻ 0.05 and **, p Ͻ 0.01 versus nonTg mice). The maximal seizure stages were 2.11 Ϯ 0.31 for nonTg mice, 1.89 Ϯ 0.29 for WT-Tg mice, 3.77 Ϯ 0.64 for G392E
hemi -Tg mice, and 4.67 Ϯ 0.50** for G392E homo -Tg mice (n ϭ 9 for each group, **, p Ͻ 0.01 versus nonTg mice). Of the four G392E homo -Tg mice classified into the highest seizure stage (stage 6), one mouse died soon after a continuous tonic-clonic seizure.
DISCUSSION
In association with FENIB, four single point mutations have been identified, resulting in amino acid substitutions in neuroserpin (S49P, S52R, H338R, and G392E) (9 -12) . The amino acid substitutions all occur in the "shutter region," which is essential for the hemi -Tg mice (D), and G392E homo -Tg mice (E) at 12-14 months of age were determined. Ho, whole brain homogenate; P1, 1,000 ϫ g pellet; P2, 17,000 ϫ g pellet; P3, 100,000 ϫ g pellet; S3, 100,000 ϫ g supernatant. NS, human neuroserpin; CyC, cytochrome c; CNX, calnexin. conformational stability of the molecule (11, 16) . Deduced from other members of the serpin family, the mutations in neuroserpin give a predictable gradation of conformational instability: G392E Ͼ H338R Ͼ S52R Ͼ S49P (25) (26) (27) (28) (29) . In FENIB, the predicted instability closely correlates with the magnitude of intracellular accumulation of neuroserpin, the severity of disease, and the age of onset of symptoms. For example, the patients with S49P mutations suffered from dementia between the ages of 40 and 60 years, whereas the onsets of disease for S52R and G392E were at 24 and 13 years, respectively (11) .
In the present study, we have established and examined novel transgenic mice overexpressing human FENIB-type G392E neuroserpin in CNS neurons. In G392E homo -Tg mice, we observed a progressive, age-dependent accumulation of G392E neuroserpin in neurons of the cerebral cortex, thalamus, amygdala, pons, and spinal cord (Figs. 2, D-F, and 3, I-L) . In contrast, the intraneuronal deposits as well as accumulation of neuroserpin were not observed in the transgenic mice overexpressing WT neuroserpin (Fig. 3, A-D) , suggesting that the mutation itself causes neuroserpin accumulation in brains of FENIB patients. Neuroserpin-immunoreactive deposits in the cerebral cortex, pons, and spinal cord were much smaller in G392E hemi -Tg mice (Fig. 3 , E-H) when compared with those in the age-matched G392E homo -Tg mice (Fig. 3, I-L) . The age-dependent accumulation of G392E neuroserpin was observed in G392E homo -Tg mice but not in G392E hemi -Tg mice in Western blot analyses (Fig. 4, A and B) , suggesting that the accumulation of G392E neuroserpin in CNS requires a threshold level of G392E neuroserpin gene expression and protein synthesis. Overall, G392E neuroserpin accumulated in CNS neurons of the G392E
homo -Tg mice in mutation-, aging-, and gene dosagedependent manners.
The possible mechanisms for increasing the synthesis of mutant neuroserpin in human FENIB patients are now thought as follows: (i) up-regulation of neuroserpin expression by various stresses and diseases such as transient cerebral ischemia, schizophrenia, and cancer (6, 30, 31) ; (ii) increased stability of neuroserpin mRNA by up-regulated expression of HuD, a neuron-specific mRNA stabilizing protein (32) ; and (iii) deficiency in ER quality control system (17) . The fact that accumulation of G392E neuroserpin in CNS requires a threshold level of gene/ protein expression in transgenic mice suggests that the downregulation of mutant neuroserpin gene expression could be one approach by which we can delay or prevent the accumulation of G392E neuroserpin in CNS of FENIB patients harboring this type of mutation.
Although Thy-1.2 promoter vigorously drives gene expression in cerebellar neurons (21), G392E neuroserpin did not accumulate in the cerebellums of G392E homo -Tg mice (Fig. 4, C  and D) . This result indicates a region-specific regulation of G392E neuroserpin accumulation in different types of neurons. The reason why G392E neuroserpin does not accumulate in cerebellar neurons is now not clear; this phenomenon, however, may contain some important clues to prevent the accumulation of this mutant form of neuroserpin (G392E).
By differential centrifugation of brain homogenates from G392E
homo -Tg mice, we have clearly shown that G392E neuroserpin recovered in the nucleus-rich fraction (1,000 ϫ g pellet; P1) dramatically increased along with aging (Fig. 5A) . Therefore, G392E neuroserpin aggregations in G392E homo -Tg brain gradually increase their densities presumably by their conversion into heavier and more compacted configurations. Cytochrome c was not recovered in the cytosolic fraction (100,000 ϫ g supernatant; S3) in any types of transgenic mice (Fig. 5, C-E) . This result suggests that the release of cytochrome c into the cytosol, a hallmark of ongoing apoptosis, is not evident in WT-Tg, G392E hemi -Tg, and G392E homo -Tg mice. As expected, the ER marker calnexin was predominantly recovered in the ER-rich fraction (100,000 ϫ g pellet; P3) in nonTg mice (Fig.  5B) . In contrast, a large amount of calnexin was recovered not only in P3 fraction but also in P1 fraction in G392E homo -Tg mice (Fig. 5E ). This result is consistent with the assumption that the heavier and more compacted aggregations of G392E neuroserpin are associated with ER.
Immunoelectron microscopy revealed that the ballooned rough ERs (rERs) with irregular form abundantly contain G392E neuroserpin (Fig. 6D, indicated by IP) . At higher magnifications, the ballooned rERs immunopositive for neuroserpin were encapsulated with dilated rER membranes (Fig. 6, E and F,  arrows) . This observation suggests that G392E neuroserpin forms irreversible polymers soon after the synthesis and folding in the ER. In fact, the ER localization of accumulated mutant neuroserpin had been previously proposed based on electron microscopic analyses of post-mortem brains of human FENIB patients (9 -12) . The colocalization of mutant neuroserpin (S49P and S52R) with calreticulin, an ER-resident protein, had also been reported in a cell culture (17) . The observation of expanded ER cisterns that contain mutant neuroserpin is basically similar to electron micrographs in brains of FENIB patients (10, 12) and in cell models overexpressing mutant antithrombin (C95R) that also belongs to the serpin gene family (33) . The localization of S49P neuroserpin in rER was recently shown in the transgenic mice (19) . At present, we do not know the significance of ballooned rERs that are immunonegative for neuroserpin (Fig. 6D, indicated by IN) ; however, it is possible that they are secondarily generated as a result of impaired function of rERs in the G392E homo -Tg mice. Intracellular accumulation of altered and misfolded proteins is an important feature of most neurodegenerative disorders. Once organized in oligomers, protofibers, and fibers, such proteins can only be removed by in-bulk degradation, such as by microautophagy or macroautophagy via the lysosomal degradation pathway (34) . In fact, we found that lysosomes with vacuoles also abundantly retain G392E neuroserpin (Fig. 6D,  indicated by L) . This phenomenon may reflect the process of lysosomal degradation of G392E neuroserpin polymers. If this is the case, an activation of the lysosomal degradation pathway in neurons could be one approach to prevent the accumulation of G392E neuroserpin in CNS of FENIB patients.
Although neuronal loss was not evident in the neocortex or hippocampus at 12 months of age, the physiological nature of cortical and hippocampal neurons may be significantly altered because of G392E neuroserpin accumulation. In the present study, we found that the susceptibility to kainate-induced seizures was already significantly increased in the G392E homo -Tg mice at 3 months of age (Fig. 7) , indicating that the neuronal excitability to excitatory amino acids is significantly altered. This is in good agreement with previous reports that epilepsy is one of the most typical symptoms seen in FENIB patients (10, 12) . Although neuroprotective roles of wild-type neuroserpin have been reported (6, 7, 18) , the Tg mice overexpressing wildtype human neuroserpin did not exhibit resistance to kainateinduced seizures (Fig. 7) . By using immunohistochemistry, we found that the expression of wild-type human neuroserpin in the hippocampal regions of WT homo -Tg mice was very low (data not shown). Because the hippocampal neurons are major sites that are damaged by kainate (7), it is possible that the expression of wild-type human neuroserpin in the hippocampus is not sufficiently high to prevent kainate-induced seizures in the WT-Tg mice.
The novel and important findings of the present study can be summarized as follows; (i) the mice recapitulated the predisposition of certain neuronal populations to develop neuroserpin aggregations especially in the neocortex, thalamus, amygdala, pons, and spinal cord; (ii) a threshold level of mutant gene expression was required for the accumulation of G392E neuroserpin in CNS neurons; (iii) the cerebeller neurons did not accumulate G392E neuroserpin; (iv) G392E neuroserpin accumulated not only in rER but also in lysosomes as evidenced by immunoelectron microscopy; and (v) neuronal excitability to excitatory amino acids was significantly altered in the mice. These findings are not documented in transgenic mice overexpressing S49P or S52R neuroserpin (19) . Although transgenic mice overexpressing S49P or S52R neuroserpin and transgenic flies overexpressing S49P, S52R, H338R, or G392E neuroserpin have been recently established (19, 35) , our transgenic mouse model will be therefore independently valuable to elucidate mechanisms for G392E neuroserpin accumulations as well as for the degradation and/or clearance of the already formed aggregations in neurons. By doing so, it should be possible to develop potential therapies for this type of FENIB (G392E).
